Stereotaxis Inc (STXS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stereotaxis Inc (STXS) has a cash flow conversion efficiency ratio of -0.364x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.20 Million) by net assets ($11.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Stereotaxis Inc market cap and net worth for the company's overall valuation and market capitalisation.
Stereotaxis Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Stereotaxis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Stereotaxis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stereotaxis Inc ranked by their cash flow conversion efficiency. Explore STXS cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shutterstock
NYSE:SSTK
|
0.002x |
|
Kaap Agri Bedryf Employee and Farm Worker Bee Trust
JSE:KAL
|
-0.022x |
|
Tonghua Grape Wine Co Ltd
SHG:600365
|
-0.411x |
|
Thanulux Public Company Limited
BK:TNL
|
-0.039x |
|
In Win Development Inc
TW:6117
|
0.006x |
|
Dynamix Corporation
NASDAQ:ETHM
|
0.214x |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
0.017x |
|
Caisse Regionale de Credit Agricole Mutuel du Languedoc
PA:CRLA
|
0.051x |
Annual Cash Flow Conversion Efficiency for Stereotaxis Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024. View Stereotaxis Inc (STXS) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $11.43 Million | $-8.50 Million | -0.743x | -78.27% |
| 2023-12-31 | $21.92 Million | $-9.14 Million | -0.417x | -58.19% |
| 2022-12-31 | $31.93 Million | $-8.41 Million | -0.264x | -252.70% |
| 2021-12-31 | $39.42 Million | $-2.95 Million | -0.075x | +14.40% |
| 2020-12-31 | $40.23 Million | $-3.51 Million | -0.087x | +46.06% |
| 2019-12-31 | $28.52 Million | $-4.62 Million | -0.162x | +53.78% |
| 2018-12-31 | $7.27 Million | $-2.55 Million | -0.350x | -254.38% |
| 2017-12-31 | $-20.61 Million | $-4.67 Million | 0.227x | -46.32% |
| 2016-12-31 | $-15.53 Million | $-6.56 Million | 0.423x | +194.59% |
| 2015-12-31 | $-17.63 Million | $-2.53 Million | 0.143x | -80.20% |
| 2014-12-31 | $-12.55 Million | $-9.09 Million | 0.724x | +33.90% |
| 2013-12-31 | $-11.70 Million | $-6.33 Million | 0.541x | -16.10% |
| 2012-12-31 | $-18.79 Million | $-12.12 Million | 0.645x | -61.54% |
| 2011-12-31 | $-18.83 Million | $-31.57 Million | 1.677x | +192.88% |
| 2010-12-31 | $10.48 Million | $-18.91 Million | -1.805x | +38.17% |
| 2009-12-31 | $7.64 Million | $-22.31 Million | -2.919x | +51.39% |
| 2008-12-31 | $4.77 Million | $-28.65 Million | -6.006x | -306.91% |
| 2007-12-31 | $24.19 Million | $-35.71 Million | -1.476x | -69.60% |
| 2006-12-31 | $44.79 Million | $-38.98 Million | -0.870x | +61.51% |
| 2005-12-31 | $18.13 Million | $-40.99 Million | -2.261x | -315.04% |
| 2004-12-31 | $58.39 Million | $-31.81 Million | -0.545x | +43.74% |
| 2003-12-31 | $25.27 Million | $-24.47 Million | -0.968x | -5.54% |
| 2002-12-31 | $24.01 Million | $-22.03 Million | -0.918x | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more